• Filter by Type

  • Filter by Program

  • Filter by Topics

Reconsidering Medicaid Privatization: Weighing the Evidence and the Alternatives
Briefs Worker Power and Economic Security

Reconsidering Medicaid Privatization: Weighing the Evidence and the Alternatives

July 18, 2023

By Naomi Zewde, Raz Edwards, Keith Gordon

More than Consumers: Post-Neoliberal Identities and Economic Governance
Reports

More than Consumers: Post-Neoliberal Identities and Economic Governance

August 3, 2022

By Suzanne Kahn

The Impact of Private Equity on Nursing Home Care: Recommendations for Policymakers
Briefs Corporate Power

The Impact of Private Equity on Nursing Home Care: Recommendations for Policymakers

April 30, 2021

By Melea Atkins

The Economy of Tomorrow: Recovering and Restructuring after COVID-19
Briefs Climate and Economic Transformation

The Economy of Tomorrow: Recovering and Restructuring after COVID-19

October 28, 2020

By Joseph Stiglitz

State Insurance Reforms and the Trade-Offs of a Public Option
Reports Macroeconomic Analysis

State Insurance Reforms and the Trade-Offs of a Public Option

June 25, 2020

By Naomi Zewde, Adam Biener

Americans Seeking Further Economic Relief Amidst COVID-19 Pandemic
Briefs Macroeconomic Analysis

Americans Seeking Further Economic Relief Amidst COVID-19 Pandemic

April 29, 2020

By Groundwork Collaborative, Roosevelt Institute

A Forward-Thinking Policy Response to the Coronavirus Recession
Working Papers Macroeconomic Analysis

A Forward-Thinking Policy Response to the Coronavirus Recession

March 18, 2020

By Mike Konczal

AT A GLANCE: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States
Fact Sheets Corporate Power

AT A GLANCE: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States

December 5, 2019

Lowering Drug Prices: A Blueprint for Reform
Reports Worker Power and Economic Security

Lowering Drug Prices: A Blueprint for Reform

November 1, 2019

By Julie Margetta Morgan, Steph Sterling

New Rules for the 21st Century: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States
Briefs Corporate Power

New Rules for the 21st Century: Corporate Power, Public Power, and the Future of Prescription Drug Policy in the United States

October 28, 2019

By Steph Sterling, Julie Margetta Morgan